Federal contractor · NORTH BILLERICA, MA

PROGENICS PHARMACEUTICALS INC

PROGENICS PHARMACEUTICALS INC received $38.4M in federal contract obligations in FY2026, on 77 awards (+12% vs FY2025). Since FY2020: $137.8M. Its largest customer was Department of Veterans Affairs ($37.7M).

Obligations · FY2026: $38.4M
New awards: 77
Sole-source: 4.7%
Single offer: 69%

UEI: YLYKVRPCTCR3
Parent company: LANTHEUS HOLDINGS, INC.

Small business

Open in the contracts explorer Relationship graph

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

3 registered entities of the same company or corporate group, $40.3M in FY2026 together.

PROGENICS PHARMACEUTICALS INCNORTH BILLERICA, MA · Family page
Reported parent$38.4M
LANTHEUS MEDICAL IMAGING, INC.NORTH BILLERICA, MA
Reported parent$1.9M
LANTHEUS HOLDINGS, INC.NORTH BILLERICA, MA
Reported parent$0

Spending by fiscal year

Obligations per federal fiscal year (October–September).

230.7KFY2020
419.6KFY2021
12.5MFY2022
26MFY2023
26MFY2024
34.2MFY2025
38.4MFY2026
0FY2027

Top buying agencies

Obligations in FY2026.

Department of Veterans Affairs$37.7M98%
73 awards
National Institutes of Health$622.3K1.6%
2 awards
Defense Health Agency$43.3K0.1%
2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$38.4M100%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition73%
US 39% · $28.2M
Sole-source awards4.7%
US 30% · $1.8M
Single-offer competitions69%
US 8.7% · $26.4M
Urgency justifications0.4%
US 5.1% · $162.4K

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

Department of Veterans Affairs$1.7M
Department of Veterans Affairs · 2 awards
National Institutes of Health$93K
Department of Health and Human Services · 1 awards

Largest awards

FLUORINE 18 PIFLUFOLASTAT - PYLARIFY$5.7M
Department of Veterans Affairs· Middlesex County, MA· Health & medical· Mar 9, 2022 – Apr 14, 2026· 36C24722N0171
PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01$4.6M
Department of Veterans Affairs· Middlesex County, MA· Health & medical· Mar 30, 2022 – Sep 24, 2026· 36C26122N0385
PYLARIFY INJECTIONS$3.7M
Department of Veterans Affairs· Middlesex County, MA· Health & medical· Dec 16, 2022 – Sep 30, 2026· 36C24723F0136
PYLARIFY RADIOPHARM$2.9M
Department of Veterans Affairs· Middlesex County, MA· Health & medical· Dec 16, 2024 – Jan 15, 2026· 36C25025N0158
PYLARIFY$2.7M
Department of Veterans Affairs· New York County, NY· Health & medical· Jun 9, 2023 – May 28, 2026· 36C24723N0444
PYLARIFY 2026 - KENT CBOC$2.4M
Department of Veterans Affairs· Middlesex County, MA· Health & medical· Feb 28, 2026 – Jun 15, 2026· 36C25026N0354
PYLARIFY - CLEVELAND VAMC$2.3M
Department of Veterans Affairs· Middlesex County, MA· Health & medical· Feb 27, 2025 – Apr 23, 2026· 36C25025F0351
SERVICE$2.1M
Department of Veterans Affairs· Allegheny County, PA· Health & medical· Mar 25, 2024 – Feb 26, 2026· 36C24424N0558

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 5 markets (agency × industry), FY2024–FY2026.

ADVANCED ACCELERATOR APPLICATIONS USA INC$81.9M+4.8% in FY2026
NEW YORK, NY · 2 entities · 74% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturingArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing
EXELAN PHARMACEUTICALS INC$179.9M+38% in FY2026
BOCA RATON, FL · 96% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
BIOMERIEUX INC$127.2M+8% in FY2026
SALT LAKE CITY, UT · 67% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturingArmy · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Across the company family of PROGENICS PHARMACEUTICALS INC (3 recipients).

Matched organizations

Lantheus Medical Imaging, Inc.AI match · 100%

Lobbying · 2025: $200K; 4 reports
Lobbying · 2023–2026: $640K

Lobbying by year

2023$160K
4 reports
2024$180K
4 reports
2025$200K
4 reports
2026$100K
2 reports

Top issues

Health issues14 reports

Who was contacted

U.S. HOUSE OF REPRESENTATIVES14 reports
U.S. SENATE14 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Farragut Partners LLP$640K
14 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Bills named in its lobbying reports

H.R. 4479 · Positioning the Election Assistance Commission for the Future Act of 20235 reports
118th Congress · Introduced · 2023–2024
S. 2609 · Small Business Growth Act5 reports
118th Congress · Introduced · 2023–2024
H.R. 4479 · To amend the National Housing Act to direct the Secretary of Housing and Urban Development to establish a program to insure certain second liens secured against property for the purpose of financing the construction of an accessory dwelling unit, and for other purposes.5 reports
119th Congress · Introduced · 2025–2026
S. 2609 · Financial Technology Protection Act of 20254 reports
119th Congress · Introduced · 2025–2026

10 of 14 reports (2023–2026) name at least one bill. Bills and resolutions the current reports name in their issue descriptions, by number of reports. A report names what it lobbied on, not which side it took.

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.